Shockwave Medical, Inc.
SWAV
$330.59
$0.100.03%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 787.97M | 730.23M | 671.28M | 616.59M | 557.17M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 787.97M | 730.23M | 671.28M | 616.59M | 557.17M |
| Cost of Revenue | 102.53M | 95.39M | 87.57M | 80.94M | 73.17M |
| Gross Profit | 685.44M | 634.84M | 583.70M | 535.65M | 484.00M |
| SG&A Expenses | 358.61M | 328.10M | 297.72M | 276.58M | 243.79M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 624.28M | 569.14M | 512.34M | 465.21M | 408.59M |
| Operating Income | 163.69M | 161.09M | 158.93M | 151.37M | 148.58M |
| Income Before Tax | 183.54M | 174.28M | 163.48M | 153.52M | 146.85M |
| Income Tax Expenses | 20.04M | 27.00M | -80.41M | -90.39M | -93.75M |
| Earnings from Continuing Operations | 163.50 | 147.28 | 243.88 | 243.90 | 240.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 163.50M | 147.28M | 243.88M | 243.90M | 240.60M |
| EBIT | 163.69M | 161.09M | 158.93M | 151.37M | 148.58M |
| EBITDA | 175.45M | 171.45M | 167.76M | 158.44M | 154.19M |
| EPS Basic | 4.42 | 4.01 | 6.71 | 6.73 | 6.65 |
| Normalized Basic EPS | 3.14 | 3.00 | 2.81 | 2.64 | 2.54 |
| EPS Diluted | 4.27 | 3.86 | 6.41 | 6.41 | 6.33 |
| Normalized Diluted EPS | 3.03 | 2.89 | 2.69 | 2.52 | 2.42 |
| Average Basic Shares Outstanding | 147.68M | 146.82M | 146.07M | 145.27M | 144.44M |
| Average Diluted Shares Outstanding | 153.05M | 152.56M | 152.40M | 152.15M | 151.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
